179 related articles for article (PubMed ID: 37028274)
1. Role of NLRP3 inflammasome in hepatocellular carcinoma: A double-edged sword.
Tang YL; Tao Y; Zhu L; Shen JL; Cheng H
Int Immunopharmacol; 2023 May; 118():110107. PubMed ID: 37028274
[TBL] [Abstract][Full Text] [Related]
2. Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis.
Zhang Y; Yang H; Sun M; He T; Liu Y; Yang X; Shi X; Liu X
Pharmacol Rep; 2020 Oct; 72(5):1370-1382. PubMed ID: 32301055
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment.
Awwad SF; Assaf RH; Emam AA; Fouad AA; Arafa LF; El-Hanafy AA
Med Oncol; 2023 Feb; 40(3):94. PubMed ID: 36763290
[TBL] [Abstract][Full Text] [Related]
4. E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells.
Wei Q; Zhu R; Zhu J; Zhao R; Li M
Oncol Res; 2019 Jul; 27(7):827-834. PubMed ID: 30940293
[TBL] [Abstract][Full Text] [Related]
5. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
Li P; Liu Y; He Q
Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
[TBL] [Abstract][Full Text] [Related]
6. Sorcin regulate pyroptosis by interacting with NLRP3 inflammasomes to facilitate the progression of hepatocellular carcinoma.
Li Z; Yang Z; Zhu Y; Fu C; Li N; Peng F
Cell Death Dis; 2023 Oct; 14(10):678. PubMed ID: 37833249
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword.
Hamarsheh S; Zeiser R
Front Immunol; 2020; 11():1444. PubMed ID: 32733479
[TBL] [Abstract][Full Text] [Related]
8. Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome.
Wei Q; Guo P; Mu K; Zhang Y; Zhao W; Huai W; Qiu Y; Li T; Ma X; Liu Y; Chen X; Han L
Lab Invest; 2015 Jul; 95(7):804-16. PubMed ID: 26006022
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 inflammasome in hepatic diseases: A pharmacological target.
Ramos-Tovar E; Muriel P
Biochem Pharmacol; 2023 Nov; 217():115861. PubMed ID: 37863329
[TBL] [Abstract][Full Text] [Related]
10. The role of NLRP3 inflammasome in hepatocellular carcinoma.
Zhao H; Zhang Y; Zhang Y; Chen C; Liu H; Yang Y; Wang H
Front Pharmacol; 2023; 14():1150325. PubMed ID: 37153780
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression.
Wei Q; Mu K; Li T; Zhang Y; Yang Z; Jia X; Zhao W; Huai W; Guo P; Han L
Lab Invest; 2014 Jan; 94(1):52-62. PubMed ID: 24166187
[TBL] [Abstract][Full Text] [Related]
12. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
Gaul S; Leszczynska A; Alegre F; Kaufmann B; Johnson CD; Adams LA; Wree A; Damm G; Seehofer D; Calvente CJ; Povero D; Kisseleva T; Eguchi A; McGeough MD; Hoffman HM; Pelegrin P; Laufs U; Feldstein AE
J Hepatol; 2021 Jan; 74(1):156-167. PubMed ID: 32763266
[TBL] [Abstract][Full Text] [Related]
14. AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.
Martínez-Cardona C; Lozano-Ruiz B; Bachiller V; Peiró G; Algaba-Chueca F; Gómez-Hurtado I; Such J; Zapater P; Francés R; González-Navajas JM
Int J Cancer; 2018 Dec; 143(11):2997-3007. PubMed ID: 30133699
[TBL] [Abstract][Full Text] [Related]
15. Shuanghua decoction exerts anticancer activity by activating NLRP3 inflammasome via ROS and inhibiting NF-κB signaling in hepatocellular carcinoma cells.
Dai B; Fan M; Huang X; Gong Z; Cao H; Hu Y; Su Q; Yang T; Chen Y; Peng X; Liu F; Zhang Y
Phytomedicine; 2022 Aug; 103():154249. PubMed ID: 35716538
[TBL] [Abstract][Full Text] [Related]
16. Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis.
Saber S; Ghanim AMH; El-Ahwany E; El-Kader EMA
Cancer Chemother Pharmacol; 2020 Feb; 85(2):331-343. PubMed ID: 31989218
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NLRP3 inflammasome-A potential mechanistic therapeutic for treatment of polycystic ovary syndrome?
Chamanara S; Hozouri V; Irandoost E
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23592. PubMed ID: 38054794
[TBL] [Abstract][Full Text] [Related]
18. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
Shim DW; Lee KH
Front Immunol; 2018; 9():1054. PubMed ID: 29868015
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation.
Xie WH; Ding J; Xie XX; Yang XH; Wu XF; Chen ZX; Guo QL; Gao WY; Wang XZ; Li D
Inflamm Res; 2020 Jul; 69(7):683-696. PubMed ID: 32347316
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits hepatocellular carcinoma development by inducing apoptosis and pyroptosis through regulating FOXO3.
Shen Z; Zhou H; Li A; Wu T; Ji X; Guo L; Zhu X; Zhang D; He X
Aging (Albany NY); 2021 Sep; 13(18):22120-22133. PubMed ID: 34546972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
